Navigation Links
Optimer Pharmaceuticals Announces Key Additions to Management Team
Date:1/10/2011

r holds a Ph.D. in philosophy, health administration from Columbia Southern, a Master of Public Administration with a specialization in health care from C.W. Post College, and a B.S. in, medical biology also from C.W. Post College.

Hemal Shah has spent more than 10 years in HEOR at Boehringer Ingelheim Pharmaceuticals, most recently as Executive Director, where she was focused on the hospital market for the launch of Spivira® for a chronic obstructive pulmonary disease.  She held positions of increasing responsibility in HEOR, implementing HEOR tools including medication adherence, healthcare reforms, health related quality of life research, health economic model development, and pharmacoeconomic analyses to support arguments for commercialization. Shah received her Doctor of Pharmacy from Rutgers State University and holds a B.S. from the University of Connecticut.

Dr. Womelsdorf has more than 15 years of experience in business development roles at Cyclacel Pharmaceuticals, Johnson & Johnson (J&J), F. Hoffmann-La Roche, Baxter International and, most recently, with his own consulting firm.  As the Vice President, Business Development at Cyclacel, he was responsible for all aspects of corporate and business development and licensing including the repositioning of key programs. During his tenure at J&J, Dr. Womelsdorf closed multiple transactions, including a deal with MGI Pharma that gave J&J rights outside North America to Dacogen™ (decitabine), a late stage oncology product with utility in Myelodysplastic Syndromes, Acute Myeloid Leukemia and other cancers. He was appointed to the Board of Tibotec Therapeutics, J&J's oncology and virology company, where he helped oversee the transition of the Company to a commercial entity culminating in the successful launch of Prezista™ (darunivir), a novel protease inhibitor for the treatment of HIV. Prior to joining J&J, he worked as a Global Licensing Director f
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent
2. Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection
3. Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
4. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
5. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
6. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
7. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
8. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
9. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... 2015  Three-month paliperidone palmitate, an investigational atypical ... placebo in patients with schizophrenia, according to a ... in the Journal of the American ... Results of the study served as the basis ... for three-month paliperidone palmitate injection to treat schizophrenia ...
(Date:3/27/2015)... 2015 BioCorRx, Inc. ( BICX ... is a healthcare solutions organization, which focuses solely ... $22 billion in the U.S. alone. The Company created a ... in a specially compounded form for outpatient surgical implantation. The ... and New Zealand ) to the specially ...
(Date:3/27/2015)... March 27, 2015 Across the global healthcare ... challenges in clinical development, market education, and regulatory compliance. ... Medical Affairs function is expected to increase in prominence ... According to research by benchmarking firm, Best ... group dedicated to Medical Affairs. Among companies in ...
Breaking Medicine Technology:New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2Medical Affairs Capabilities Expanding in Emerging Marketplaces 2
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 How ... is a growing field in orthopaedic medicine. While diagnostic ... tear to confirm the pain etiology, research presented today ... AOSSM ) Specialty Day suggests that pain relief from ... arthroscopic hip surgery. , “Our study looked to ...
(Date:3/28/2015)... 28, 2015 Early surgery may not ... V AC joint injuries, according to new research from ... the American Orthopaedic Society for Sports Medicine’s ( AOSSM ... faster when surgery was not performed. , The final ... surgical treatment and 17 receiving non-surgical therapy. Of the ...
(Date:3/28/2015)... California (PRWEB) March 28, 2015 Andrew Hawley ... original 1960's Who psychedelic concert posters. The Who and the ... York on August 2, 1968. According to Hawley, “The Who ... many concert halls and college campuses. Perhaps the most famous ... with Jim Morrison and the Doors on August 2, 1968 ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:3/28/2015)... 28, 2015 The "Petrick Sustainable ... sustainable health. After 18 years of research and experience ... UFC contenders, Dr. Jon Petrick is excited to be ... some of the immediate benefits of this radical new ... levels of strength of the immune system, faster healing ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2
... of bird flu in Serbia has been reported, much to ... Bosnian border // has been suspected of carrying the deadly ... Bajina Basta, in the eastern Serbian region have been found ... animals have been sent to testing laboratory in Britain to ...
... the journal Cancer Research says that tumors treated with ... size. // It was also found that this ingredient ... Center studied the effect of pepper in mice, who ... ,The mice were treated to 400 milligrams of ...
... chip or whatever fancy name you could possibly conjure to ... dates and events, with such detail, that has caught the ... to remember big events, garnished with minute details, like a ... such an astounding memory, that could put even a computer ...
... scare besides taking poultry life is also incurring huge financial losses. ... poultry farmers in Kerala,// badly hitting the over Rs 2500 crore ... Kerala Poultry Farmers and Traders Association. , ,Millions of eggs ... fear about avian flu spread in the state. The prices of ...
... University School of Medicine in St. Louis have investigated ... They have found that pills containing plant substances called ... ,The study samples were patients already on a heart-healthy ... were asked to add plant sterol pill to the ...
... hearing of India's biggest ever medical compensation claim against doctors ... death eight years ago.// ,"I am hopeful about ... by the machinations of my opponents," Ohio-based AIDS researcher Kunal ... hearing at the National Consumer Disputes Redressal Commission (NCDRC). ...
Cached Medicine News:Health News:Chip of a Woman: A 'Human Dairy', Who Has Scientists’ Eating Out Of Her Hands 2Health News:Plants have ability to significantly lower LDL cholesterol through sterol pills 2Health News:Stage Set For Final Hearing On India’s Biggest Ever Medical Compensation Clai 2
... floor-standing centrifuge. Compact, swing-out rotor, performs ... 3 liter models, microprocessor control, lifetime ... adaptors, informative display, display in 4 ... rates (100 run profiles), powerful refrigeration, ...
High speed, programmable refrigerated centrifuge. High efficiency separations, "Like clockwork" accuracy, aerosol containment, Accommodating, Re-Run control, Glove-Friendly membrane, centrifuge statu...
... 460 family of centrifuges ... that meets a wide ... feature high capacity, versatility ... technology and high safety ...
The Quantum performs centrifugal blood cell separations, urine separations, and sperm cell washing. 24 place angle head, variable speed, and automatic braking system, calibrated variable speed....
Medicine Products: